News
Market
Jobs
About
Contact
List Product
Register
Login
Generate
WhatsApp Message
*Zimbabwe Becomes First African Country To Approve Use Of New HIV Drug* *Follow Pindula on WhatsApp for daily new updates* https://whatsapp.com/channel/0029Va84dngJP21B2nWeyM3v?si Zimbabwe has become the first African country to approve the use of long-acting injectable, Cabotegravir (CAB-LA), a pre-exposure prophylaxis (Prep) dose for HIV prevention. The Medicines Control Authority of Zimbabwe (MCAZ) on Monday announced the approval of the use of the drug. ---------- Pindula is best experienced with the Android App. *Download APK here:* https://zero.pindula.co.zw/media/apps/apks/pindula23.apk _On Econet, Pindula does NOT use your data_ ---------- According to the World Health Organisation (WHO), “CAB-LA may be offered to people at substantial risk of HIV acquisition as part of comprehensive HIV prevention approaches”. CAB-LA injections are to be taken every two months and studies have shown that they are highly effective in reducing the risk of HIV acquisition among homosexual men, transgender, and cisgender women. Community Working Group on Health (CWGH) executive director Itai Rusike applauded the move to approve the use of the drug in Zimbabwe. He said: > Prep dramatically reduces the risk of HIV acquisition for women as well as men. > We are aware that for more than a decade, WHO has recommended that pregnant and breastfeeding women at risk of HIV should be offered Prep. > The people of Zimbabwe should embrace this new development in order to reduce the risk of HIV infection. Development Agenda for Girls and Women in Africa Network representative Nyasha Sithole said “this will contribute to our basket of HIV prevention tools that work for us as girls and women in Zimbabwe”. | NewsDay itel A50 now available on Pindula at $84 64GB storage, 2GB RAM. _ideal for light usage_ _If you found this article useful_ *Please support Pindula by forwarding to friends and groups*
Copy to clipboard
Give us Feedback
Full Name
WhatsApp Number
Feedback
Submit
Feedback